Yasuto Kido

1.3k total citations
18 papers, 881 citations indexed

About

Yasuto Kido is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Yasuto Kido has authored 18 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in Molecular Biology. Recurrent topics in Yasuto Kido's work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Amino Acid Enzymes and Metabolism (3 papers). Yasuto Kido is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Amino Acid Enzymes and Metabolism (3 papers). Yasuto Kido collaborates with scholars based in Japan, United States and Ireland. Yasuto Kido's co-authors include Ikumi Tamai, Akira Tsuji, Yoshimichi Sai, Kathleen M. Giacomini, Pär Matsson, Fumio Suzuki, Junko Yamashita, Hiroko Nikaido, Jun‐ichi Nezu and Noriyoshi Hashimoto and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Yasuto Kido

17 papers receiving 873 citations

Peers

Countries citing papers authored by Yasuto Kido

Since Specialization

Citations

This map shows the geographic impact of Yasuto Kido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuto Kido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuto Kido more than expected).

Fields of papers citing papers by Yasuto Kido

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuto Kido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuto Kido. The network helps show where Yasuto Kido may publish in the future.

Co-authorship network of co-authors of Yasuto Kido

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuto Kido. A scholar is included among the top collaborators of Yasuto Kido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuto Kido. Yasuto Kido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Investigation of an OATP1B inhibitory effect by a cyclic peptide using the endogenous biomarker coproporphyrin-I in monkeys 2025 ·Drug Metabolism and Pharmacokinetics ·(unknown), Yasuto Kido, Makoto Iwasaki, (unknown), (unknown), (unknown)	0
2	Minimal Involvement of P-gp and BCRP in Oral Absorption of Ensitrelvir, An Oral SARS-CoV-2 3C-like Protease Inhibitor, in a Non-Clinical Investigation 2024 ·Journal of Pharmaceutical Sciences ·(unknown), (unknown), Shinpei Yoshida, Yasuto Kido, Takanobu Matsuzaki	2
3	Prediction of drug-drug interaction risk of P-glycoprotein substrate in drug discovery 2024 ·Drug Metabolism and Pharmacokinetics ·Yasuto Kido, (unknown), Takanobu Matsuzaki, (unknown), (unknown), (unknown), Tomohiko Okuda	5
4	Identification of Food-Derived Isoflavone Sulfates as Inhibition Markers for Intestinal Breast Cancer Resistance Proteins 2021 ·Drug Metabolism and Disposition ·(unknown), Yusuke Masuo, Yasuto Kido, (unknown), Takahiro Ishimoto, Yukio Kato	3
5	Balancing potency and basicity by incorporating fluoropyridine moieties: Discovery of a 1-amino-3,4-dihydro-2,6-naphthyridine BACE1 inhibitor that affords robust and sustained central Aβ reduction 2021 ·European Journal of Medicinal Chemistry ·Kenji Nakahara, (unknown), (unknown), Takahiko Yamamoto, Shiho Yamamoto, Hisanori Ito, Yasuto Kido, Ken‐ichi Kusakabe	4
6	Species difference in brain penetration of P-gp and BCRP substrates among monkey, dog and mouse 2021 ·Drug Metabolism and Pharmacokinetics ·Yasuto Kido, (unknown), (unknown), Takanobu Matsuzaki, (unknown), (unknown), Makoto Iwasaki, (unknown), (unknown), Tomohiko Okuda	16
7	Highly Conformationally Restricted Cyclopropane Tethers with Three‐Dimensional Structural Diversity Drastically Enhance the Cell Permeability of Cyclic Peptides 2017 ·Chemistry - A European Journal ·Kouhei Matsui, Yasuto Kido, (unknown), Yousuke Kashima, (unknown), Satoshi Shuto	18
8	Highly Conformationally Restricted Cyclopropane Tethers with Three‐Dimensional Structural Diversity Drastically Enhance the Cell Permeability of Cyclic Peptides 2016 ·Chemistry - A European Journal ·Kouhei Matsui, Yasuto Kido, (unknown), Yousuke Kashima, Yutaka Yoshida, Satoshi Shuto	26
9	Discovery of Potent, Selective Multidrug and Toxin Extrusion Transporter 1 (MATE1, SLC47A1) Inhibitors Through Prescription Drug Profiling and Computational Modeling 2012 ·Journal of Medicinal Chemistry ·Matthias Wittwer, Arik A. Zur, Natalia Khuri, Yasuto Kido, Alan Kosaka, Xuexiang Zhang, Kari M. Morrissey, Andrej Săli, Yong Huang, Kathleen M. Giacomini	118
10	Profiling of a Prescription Drug Library for Potential Renal Drug–Drug Interactions Mediated by the Organic Cation Transporter 2 2011 ·Journal of Medicinal Chemistry ·Yasuto Kido, Pär Matsson, Kathleen M. Giacomini	131
11	Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa 2007 ·Reproduction ·Daisuke Kobayashi, Ikumi Tamai, Yoshimichi Sai, Kazuhiro Yoshida, Tomohiko Wakayama, Yasuto Kido, (unknown), Shoichi Iseki, Akira Tsuji	33
12	Evaluation of Blood-brain Barrier Transporters by Co-culture of Brain Capillary Endothelial Cells with Astrocytes 2002 ·Drug Metabolism and Pharmacokinetics ·Yasuto Kido, Ikumi Tamai, Takeo Nakanishi, (unknown), (unknown), Yoshimichi Sai, Akira Tsuji	28
13	Functional relevance of carnitine transporter OCTN2 to brain distribution ofl‐carnitine and acetyl‐l‐carnitine across the blood–brain barrier 2001 ·Journal of Neurochemistry ·Yasuto Kido, Ikumi Tamai, (unknown), Yoshimichi Sai, (unknown), Jun‐ichi Nezu, Hiroko Nikaido, Noriyoshi Hashimoto, Masahide Asano, Akira Tsuji	142
14	Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier 2001 ·Journal of Pharmacy and Pharmacology ·Yasuto Kido, Ikumi Tamai, Hiroshi Uchino, Fumio Suzuki, Yoshimichi Sai, Akira Tsuji	71
15	Limited Distribution of New Quinolone Antibacterial Agents into Brain Caused by Multiple Efflux Transporters at the Blood-Brain Barrier 2000 ·Journal of Pharmacology and Experimental Therapeutics ·Ikumi Tamai, Junko Yamashita, Yasuto Kido, (unknown), Yoshimichi Sai, (unknown), Kazumasa Naruhashi, Shoichi Koizumi, Akira Tsuji	70
16	Blood-Brain Barrier Transport of H1-Antagonist Ebastine and its Metabolite Carebastine 2000 ·Journal of drug targeting ·Ikumi Tamai, Yasuto Kido, Junko Yamashita, Yoshimichi Sai, Akira Tsuji	31
17	Functional Clarification of MCT1-Mediated Transport of Monocarboxylic Acids at the Blood-Brain Barrier Using In Vitro Cultured Cells and In Vivo BUI Studies 2000 ·Pharmaceutical Research ·Yasuto Kido, Ikumi Tamai, (unknown), Fumio Suzuki, Akira Tsuji	92
18	Immunohistochemical and Functional Characterization of pH-dependent Intestinal Absorption of Weak Organic Acids by the Monocarboxylic Acid Transporter MCT1 1999 ·Journal of Pharmacy and Pharmacology ·Ikumi Tamai, Yoshimichi Sai, (unknown), Yasuto Kido, Hikaru Yabuuchi, Hitomi Takanaga, (unknown), Takuo Ogihara, Osamu Amano, (unknown), Akira Tsuji	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact